Gareth Rivalland - Concepedia

Author

Gareth Rivalland

Olivia Newton-John Cancer Wellness & Research Centre

Also Known As

G Rivalland, G. Rivalland, Gareth Rivalland

Publications

543

Citations

H-Index

Concepts

All Affiliations

Olivia Newton-John Cancer Wellness & Research Centre Auckland City Hospital The University of Melbourne Shanghai Pulmonary Hospital Austin Health

About

Gareth Rivalland is an author at Olivia Newton-John Cancer Wellness & Research Centre specializing in medicine, radiation oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	156
2	Immunology	4	4	103
3	Health Sciences	1	1	13
4	Cell Biology	1	1	19
5	Emergency Medicine	1	1	20

Gareth Rivalland

Publications

431

Citations

H-Index

Page 1

	Year	Citations
Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial Caicun Zhou, Dingzhi Huang, Yun Fan, Journal of Thoracic Oncology	2022	97
Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma Yannis Metaxas, Gareth Rivalland, Laetitia Mauti, Journal of Thoracic Oncology Malignant DiseaseRadiation OncologyPalliative ImmunotherapyPleural Disease	2018	91
The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression Shengxiang Ren, Qinrui Tian, Nadav Amar, Lung Cancer Immune CheckpointCancer ImmunosurveillancePd-l1 ExpressionImmunologyBronchial Neoplasm	2018	50
NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer José Luis Leal, Geoffrey Peters, Marcin Szaumkessel, Lung Cancer Pulmonary Neuroendocrine TumoursMalignant Pleural MesotheliomaPathologyBronchial NeoplasmPleural Disease	2020	33
Loss of STING expression is prognostic in non–small cell lung cancer Zoltán Lohinai, Dávid Dóra, Charles W. Caldwell, Journal of Surgical Oncology	2022	26
Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma Natasha K. Brockwell, Muhammad Alamgeer, Beena Kumar, Translational Lung Cancer Research	2020	24
Outcomes of anti-PD-1 therapy in mesothelioma and correlation with PD-L1 expression. Gareth Rivalland, Steven Kao, Nick Pavlakis, Journal of Clinical Oncology Pd-l1 ExpressionAnti-pd-1 TherapyPd-l1 PositivityMedicineMalignant Disease	2017	21
Pulmonary Barotrauma and Cerebral Arterial Gas Embolism During Hyperbaric Oxygen Therapy Gareth Rivalland, Simon J Mitchell, Johan M. van Schalkwyk Aviation Space and Environmental Medicine Pulmonary EmbolismThrombosisPulmonary CirculationInterventional NeuroradiologyMedicine	2010	20
Small cell lung cancer: The immune microenvironment and prognostic impact of checkpoint expression. Gareth Rivalland, Marzena Walkiewicz, Gavin Wright, Journal of Clinical Oncology Immune MicroenvironmentImmunologyImmunoeditingPathologyImmunotherapeutics	2017	19
Cardiac Troponin I and T in Checkpoint Inhibitor–associated Myositis and Myocarditis Edmond Ang, Angela Mweempwa, Campbell Le Heron, Journal of Immunotherapy	2021	15

Page 1